Belite Bio

Forecast & Rating9 analysts currently cover Belite Bio, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $228.89, about 36.8% upside from the current price of $167.33. Price targets range from $185.00 to $303.00 — a wide spread, showing clear disagreement over just how much Belite Bio can rise. Historically, about 66.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Belite Bio closely still see room for the stock to rise. Data as of Sep 9, 2026; for reference only and not investment advice.